The lack of healthcare workers worldwide is estimated by the World Health Organization (WHO) to be 7.2 million, and it is expected to increase to 12.9 million by 2035. People are living longer with more co-morbidities worldwide, necessitating more access to and usage of medications. A vital part of the healthcare sector, pharmacists are also the most accessible healthcare professionals in many nations. This study highlights the main problems and contemporary patterns influencing the pharmacy profession worldwide, with a focus on workforce gender balance, capacity, workforce dispersion, and national economic standing. Techniques: To get country-level statistics on the pharmacy workforce, national professional pharmacy leadership organizations were contacted along with additional contacts for professional bodies, regulatory authorities, and universities. To evaluate the pharmacy workforce in each nation, a descriptive and comparative study was carried out. The study received responses from 89 nations and territories. The population density of pharmacists (per 10,000 people) was analyzed in order to standardize the capacity measure. Six pharmacists per 10,000 people (n = 80) was the sample mean. The number of pharmacists per 10,000 people varies greatly throughout the countries/territories examined, ranging from 0.02 (Somalia) to 25.07 (Malta). There are far fewer pharmacists per capita in African countries. Health spending and gross national income (GNI) are correlated with pharmacist density. The majority of pharmacists work in community settings, with hospital, industrial, academic, and regulatory contexts coming in second and third, respectively. The percentage of women working in pharmacies is higher worldwide; in some WHO areas, the percentage of women in the workforce is above 65% and is on the rise. The personnel capacity of pharmacies varies significantly among nations and regions and is often correlated with economic factors at the national and population levels. There are often fewer pharmacists and pharmacy technicians in nations and territories with poorer economic indices; this has consequences for disparities in access to medications and medical knowledge.